Guardant Health Hits Record High After Earnings Beat and Raised Full-Year Outlook

Investor enthusiasm followed an outlook hike to $965–$970 million for the full year.

Overview

Revenue rose 38.7% year over year to $265 million, driven by strength across the business.
Net loss narrowed 13.9% to $92.7 million compared with the prior year period.
The company lifted its full-year revenue guidance to $965 million–$970 million from $915 million–$925 million.
Shares reached an intraday high of $95.88 and closed up 27.87% at $92.41.
The coverage also carried editorial promotion from Insider Monkey positioning AI stocks as potentially more attractive than Guardant.